Literature DB >> 30888474

The "Short-Cut" Laparoscopic Reverse Approach: A Novel Strategy for Synchronous Colorectal Cancer and Liver Metastases Requiring Major or Complex Procedures?

Mehdi Karoui1, Olivier Scatton2,3.   

Abstract

AIM: To report on the feasibility and the safety of a novel strategy in patients with colorectal cancer and synchronous liver metastases (SLM) requiring major or complex procedures for both the primary and liver deposits. PATIENTS AND METHODS: The strategy consisted in performing the two major procedures (liver first and colorectal) by laparoscopy within a short interval in order to keep both oncological advantages and short-terms outcome benefits.
RESULTS: Two patients were treated with this strategy: one with a laparoscopic resection of segment VIII extended to the segment IVb followed by the laparosopic rectal resection; the second with a laparoscopic left hepatectomy with a microwave ablation of the lesion located in the segment VII followed by the laparoscopic resection of the sigmoid colon. Postoperative courses were uneventful.
CONCLUSION: The "short-cut" laparoscopic reverse approach may represent an attractive option for patients requiring major liver and colorectal resections for SLM provided expertise in laparoscopic surgery in both fields is ensured.

Entities:  

Mesh:

Year:  2019        PMID: 30888474     DOI: 10.1007/s00268-019-04983-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  8 in total

Review 1.  Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies.

Authors:  M E Kelly; G Spolverato; G N Lê; M N Mavros; F Doyle; T M Pawlik; D C Winter
Journal:  J Surg Oncol       Date:  2014-10-31       Impact factor: 3.454

2.  Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: a propensity score matching analysis.

Authors:  Hadrien Tranchart; David Fuks; Luca Vigano; Stefano Ferretti; François Paye; Go Wakabayashi; Alessandro Ferrero; Brice Gayet; Ibrahim Dagher
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

Review 3.  Laparoscopic versus open surgery for rectal cancer: A meta-analysis of classic randomized controlled trials and high-quality Nonrandomized Studies in the last 5 years.

Authors:  Ke Chen; Guodong Cao; Bo Chen; Mingqing Wang; Xingyu Xu; Wenwen Cai; Yicheng Xu; Maoming Xiong
Journal:  Int J Surg       Date:  2017-01-11       Impact factor: 6.071

4.  Laparoscopic liver resection for colorectal liver metastasis patients allows patients to start adjuvant chemotherapy without delay: a propensity score analysis.

Authors:  Takayuki Kawai; Claire Goumard; Florence Jeune; Eric Savier; Jean-Christophe Vaillant; Olivier Scatton
Journal:  Surg Endosc       Date:  2018-01-16       Impact factor: 4.584

5.  Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial.

Authors:  Åsmund Avdem Fretland; Vegar Johansen Dagenborg; Gudrun Maria Waaler Bjørnelv; Airazat M Kazaryan; Ronny Kristiansen; Morten Wang Fagerland; John Hausken; Tor Inge Tønnessen; Andreas Abildgaard; Leonid Barkhatov; Sheraz Yaqub; Bård I Røsok; Bjørn Atle Bjørnbeth; Marit Helen Andersen; Kjersti Flatmark; Eline Aas; Bjørn Edwin
Journal:  Ann Surg       Date:  2018-02       Impact factor: 12.969

6.  Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.

Authors:  G Mentha; P E Majno; A Andres; L Rubbia-Brandt; P Morel; A D Roth
Journal:  Br J Surg       Date:  2006-07       Impact factor: 6.939

Review 7.  Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.

Authors:  René Adam; Aimery de Gramont; Joan Figueras; Norihiro Kokudo; Francis Kunstlinger; Evelyne Loyer; Graeme Poston; Philippe Rougier; Laura Rubbia-Brandt; Alberto Sobrero; Catherine Teh; Sabine Tejpar; Eric Van Cutsem; Jean-Nicolas Vauthey; Lars Påhlman
Journal:  Cancer Treat Rev       Date:  2015-06-30       Impact factor: 12.111

8.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Authors:  E Van Cutsem; A Cervantes; R Adam; A Sobrero; J H Van Krieken; D Aderka; E Aranda Aguilar; A Bardelli; A Benson; G Bodoky; F Ciardiello; A D'Hoore; E Diaz-Rubio; J-Y Douillard; M Ducreux; A Falcone; A Grothey; T Gruenberger; K Haustermans; V Heinemann; P Hoff; C-H Köhne; R Labianca; P Laurent-Puig; B Ma; T Maughan; K Muro; N Normanno; P Österlund; W J G Oyen; D Papamichael; G Pentheroudakis; P Pfeiffer; T J Price; C Punt; J Ricke; A Roth; R Salazar; W Scheithauer; H J Schmoll; J Tabernero; J Taïeb; S Tejpar; H Wasan; T Yoshino; A Zaanan; D Arnold
Journal:  Ann Oncol       Date:  2016-07-05       Impact factor: 32.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.